Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1226616/000156459018025198/mnov-8k_20181026.htm
August 2023
June 2023
June 2023
April 2023
June 2022
June 2022
April 2022
August 2021
July 2021
June 2021
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1226616/000156459018025198/mnov-8k_20181026.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Medicinova Inc.
Medicinova Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:
Ticker: MNOVEvents:
CIK: 1226616
Form Type: 8-K Corporate News
Accession Number: 0001564590-18-025198
Submitted to the SEC: Fri Oct 26 2018 6:10:54 AM EST
Accepted by the SEC: Fri Oct 26 2018
Period: Friday, October 26, 2018
Industry: Pharmaceutical Preparations